2023 Q4 Form 10-K Financial Statement

#000121390024017740 Filed on February 28, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023 Q2
Revenue $29.82M $14.80M $14.20M
YoY Change 41.63% 48.7%
Cost Of Revenue $14.04M $13.70M
YoY Change
Gross Profit $15.78M $15.08M
YoY Change
Gross Profit Margin 52.93% 101.83%
Selling, General & Admin $675.5K $546.2K
YoY Change
% of Gross Profit 4.28% 3.62%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $394.0K $14.24M $13.50M
YoY Change 45.78% 86.88%
Operating Profit $15.39M $830.9K -$13.24M
YoY Change -108.73% 90.59%
Interest Expense $6.563M $11.50M
YoY Change 63.92%
% of Operating Profit 42.64% 1384.05%
Other Income/Expense, Net
YoY Change
Pretax Income $21.95M $33.85M
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $21.95M $33.85M $23.94M
YoY Change -601.11% -136.64%
Net Earnings / Revenue 73.61% 228.68% 168.59%
Basic Earnings Per Share $1.30 $0.94
Diluted Earnings Per Share $0.67 $1.30 $0.94
COMMON SHARES
Basic Shares Outstanding 26.67M shares 25.79M shares 25.04M shares
Diluted Shares Outstanding 26.02M shares 25.45M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.117M $3.411M
YoY Change
Cash & Equivalents $2.117M $3.411M $6.737M
Short-Term Investments
Other Short-Term Assets $30.10K $620.2K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $4.609M $12.54M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.109B $1.105B
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.117B $1.112B
YoY Change
TOTAL ASSETS
Total Short-Term Assets $4.609M $12.54M
Total Long-Term Assets $1.117B $1.112B
Total Assets $1.122B $1.125B $1.082B
YoY Change 6.09% 10.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.71M $35.23M
YoY Change
Accrued Expenses $1.068M $901.1K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $18.03M $45.39M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $641.8M $632.5M
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $641.8M $632.5M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $18.03M $45.39M
Total Long-Term Liabilities $641.8M $632.5M
Total Liabilities $659.9M $677.9M $655.1M
YoY Change -4.92% 4.94%
SHAREHOLDERS EQUITY
Retained Earnings -$58.73M -$66.41M
YoY Change -46.85% -22.84%
Common Stock $520.7M $26.67K $25.77K
YoY Change 2143805.01% 14.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $462.0M $446.9M $426.5M
YoY Change
Total Liabilities & Shareholders Equity $1.122B $1.125B $1.082B
YoY Change 6.09% 10.28%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $21.95M $33.85M $23.94M
YoY Change -601.11% -136.64%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $3.407M $16.14M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.700M -14.38M
YoY Change
NET CHANGE
Cash From Operating Activities 3.407M 16.14M
Cash From Investing Activities
Cash From Financing Activities -4.700M -14.38M
Net Change In Cash -1.294M 1.760M
YoY Change
FREE CASH FLOW
Cash From Operating Activities $3.407M $16.14M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-3.22
CY2023 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
4.20
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25700603 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15494614 shares
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
usd
CY2023 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
usd
CY2023 cik0001794776 Distributions Payable
DistributionsPayable
usd
CY2022 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-56126
CY2023 dei Entity Registrant Name
EntityRegistrantName
Palmer Square Capital BDC Inc.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-3665200
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
1900 Shawnee Mission Parkway
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 315
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Mission Woods
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
KS
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
66205
CY2023 dei City Area Code
CityAreaCode
(816)
CY2023 dei Local Phone Number
LocalPhoneNumber
994-3200
CY2023 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2023 dei Trading Symbol
TradingSymbol
PSBD
CY2023 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32552794 shares
CY2023 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2023 dei Auditor Location
AuditorLocation
Kansas City, Missouri
CY2023 dei Auditor Firm
AuditorFirmId
238
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1159135422 usd
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1120099935 usd
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1108810753 usd
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1017211732 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2117109 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1650801 usd
CY2023Q4 us-gaap Receivable Investment Sale
ReceivableInvestmentSale
97141 usd
CY2022Q4 us-gaap Receivable Investment Sale
ReceivableInvestmentSale
31014356 usd
CY2023Q4 cik0001794776 Receivable For Paydowns Of Investments
ReceivableForPaydownsOfInvestments
344509 usd
CY2022Q4 cik0001794776 Receivable For Paydowns Of Investments
ReceivableForPaydownsOfInvestments
136119 usd
CY2023Q4 cik0001794776 Due From Investment Adviser
DueFromInvestmentAdviser
1718960 usd
CY2022Q4 cik0001794776 Due From Investment Adviser
DueFromInvestmentAdviser
234102 usd
CY2023Q4 us-gaap Dividends Receivable
DividendsReceivable
301637 usd
CY2022Q4 us-gaap Dividends Receivable
DividendsReceivable
141997 usd
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
8394509 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
6465594 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
30100 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
598327 usd
CY2023Q4 us-gaap Assets
Assets
1121814718 usd
CY2022Q4 us-gaap Assets
Assets
1057453028 usd
CY2023Q4 us-gaap Line Of Credit
LineOfCredit
641828805 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
641309417 usd
CY2023Q4 us-gaap Payable Investment Purchase
PayableInvestmentPurchase
14710524 usd
CY2022Q4 us-gaap Payable Investment Purchase
PayableInvestmentPurchase
42750748 usd
CY2022Q4 us-gaap Distribution Payable
DistributionPayable
6941066 usd
CY2023Q4 us-gaap Management Fee Payable
ManagementFeePayable
2252075 usd
CY2022Q4 us-gaap Management Fee Payable
ManagementFeePayable
1872815 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
1067921 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
1135500 usd
CY2023Q4 us-gaap Liabilities
Liabilities
659859325 usd
CY2022Q4 us-gaap Liabilities
Liabilities
694009546 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
450000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27102794 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27102794 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24286628 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24286628 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
27103 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
24287 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
520663106 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
473921377 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58734816 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-110502182 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
461955393 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
363443482 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1121814718 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1057453028 usd
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
17.04
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.96
CY2023 us-gaap Interest And Other Income
InterestAndOtherIncome
107739382 usd
CY2022 us-gaap Interest And Other Income
InterestAndOtherIncome
73705450 usd
CY2021 us-gaap Interest And Other Income
InterestAndOtherIncome
38897216 usd
CY2023 us-gaap Investment Income Dividend
InvestmentIncomeDividend
4066745 usd
CY2022 us-gaap Investment Income Dividend
InvestmentIncomeDividend
610203 usd
CY2021 us-gaap Investment Income Dividend
InvestmentIncomeDividend
9597 usd
CY2023 us-gaap Other Income
OtherIncome
417480 usd
CY2022 us-gaap Other Income
OtherIncome
184247 usd
CY2021 us-gaap Other Income
OtherIncome
778840 usd
CY2023 us-gaap Investment Income Net
InvestmentIncomeNet
112223607 usd
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
74499900 usd
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
39685653 usd
CY2023 us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
112223607 usd
CY2022 us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
74499900 usd
CY2021 us-gaap Gross Investment Income Operating
GrossInvestmentIncomeOperating
39685653 usd
CY2023 us-gaap Interest Expense
InterestExpense
44483152 usd
CY2022 us-gaap Interest Expense
InterestExpense
23452169 usd
CY2021 us-gaap Interest Expense
InterestExpense
8616661 usd
CY2023 us-gaap Management Fee Expense
ManagementFeeExpense
8408074 usd
CY2022 us-gaap Management Fee Expense
ManagementFeeExpense
8328713 usd
CY2021 us-gaap Management Fee Expense
ManagementFeeExpense
6369583 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
792645 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
741961 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
758435 usd
CY2023 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
75000 usd
CY2022 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
75000 usd
CY2021 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
75000 usd
CY2023 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1528225 usd
CY2022 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1862314 usd
CY2021 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1827931 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
55287096 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
34460157 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
17647610 usd
CY2023 us-gaap Other Operating Income
OtherOperatingIncome
1051009 usd
CY2022 us-gaap Other Operating Income
OtherOperatingIncome
1041089 usd
CY2021 us-gaap Other Operating Income
OtherOperatingIncome
796198 usd
CY2023 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-54236087 usd
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-33419068 usd
CY2021 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-16851412 usd
CY2023 us-gaap Net Investment Income
NetInvestmentIncome
57987520 usd
CY2022 us-gaap Net Investment Income
NetInvestmentIncome
41080832 usd
CY2021 us-gaap Net Investment Income
NetInvestmentIncome
22834241 usd
CY2023 cik0001794776 Non Affiliate Non Control Investments
NonAffiliateNonControlInvestments
-2715413 usd
CY2022 cik0001794776 Non Affiliate Non Control Investments
NonAffiliateNonControlInvestments
-8130187 usd
CY2021 cik0001794776 Non Affiliate Non Control Investments
NonAffiliateNonControlInvestments
4753263 usd
CY2023 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-2715413 usd
CY2022 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-8130187 usd
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
4753263 usd
CY2023 cik0001794776 Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments
UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments
-52563544 usd
CY2022 cik0001794776 Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments
UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments
107432980 usd
CY2021 cik0001794776 Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments
UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments
8527786 usd
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
52563544 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-107432980 usd
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-8527786 usd
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
49848131 usd
CY2022 us-gaap Gain Loss On Investments
GainLossOnInvestments
-115563167 usd
CY2021 us-gaap Gain Loss On Investments
GainLossOnInvestments
-3774523 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
107835651 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-74482335 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
19059718 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.26
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.78
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.47
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
4.2
CY2022 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-3.22
CY2021 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.23
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25700603 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23130666 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15494614 shares
CY2023 us-gaap Net Investment Income
NetInvestmentIncome
57987520 usd
CY2022 us-gaap Net Investment Income
NetInvestmentIncome
41080832 usd
CY2021 us-gaap Net Investment Income
NetInvestmentIncome
22834241 usd
CY2023 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-2715413 usd
CY2022 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-8130187 usd
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
4753263 usd
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
52563544 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-107432980 usd
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-8527786 usd
CY2023 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
107835651 usd
CY2022 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-74482335 usd
CY2021 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
19059718 usd
CY2023 cik0001794776 Dividends And Distributions To Stockholders
DividendsAndDistributionsToStockholders
56068285 usd
CY2022 cik0001794776 Dividends And Distributions To Stockholders
DividendsAndDistributionsToStockholders
43102007 usd
CY2021 cik0001794776 Dividends And Distributions To Stockholders
DividendsAndDistributionsToStockholders
17845775 usd
CY2022 cik0001794776 Distributions Declared From Realized Gains
DistributionsDeclaredFromRealizedGains
953110 usd
CY2021 cik0001794776 Distributions Declared From Realized Gains
DistributionsDeclaredFromRealizedGains
8106718 usd
CY2023 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-56068285 usd
CY2022 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-44055117 usd
CY2021 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-25952493 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
17654225 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5023801 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
188861571 usd
CY2023 cik0001794776 Reinvestment Of Distributions During The Period
ReinvestmentOfDistributionsDuringThePeriod
29090320 usd
CY2022 cik0001794776 Reinvestment Of Distributions During The Period
ReinvestmentOfDistributionsDuringThePeriod
24159545 usd
CY2021 cik0001794776 Reinvestment Of Distributions During The Period
ReinvestmentOfDistributionsDuringThePeriod
17683821 usd
CY2023 cik0001794776 Net Increase In Net Assets From Capital Share Transactions
NetIncreaseInNetAssetsFromCapitalShareTransactions
46744545 usd
CY2022 cik0001794776 Net Increase In Net Assets From Capital Share Transactions
NetIncreaseInNetAssetsFromCapitalShareTransactions
29183346 usd
CY2021 cik0001794776 Net Increase In Net Assets From Capital Share Transactions
NetIncreaseInNetAssetsFromCapitalShareTransactions
206545392 usd
CY2023 cik0001794776 Total Increase Decrease In Net Assets
TotalIncreaseDecreaseInNetAssets
98511911 usd
CY2022 cik0001794776 Total Increase Decrease In Net Assets
TotalIncreaseDecreaseInNetAssets
-89354106 usd
CY2021 cik0001794776 Total Increase Decrease In Net Assets
TotalIncreaseDecreaseInNetAssets
199652617 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
363443482 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
452797588 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
253144971 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
461955393 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
363443482 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
452797588 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
107835651 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-74482335 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
19059718 usd
CY2023 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-2715413 usd
CY2022 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-8130187 usd
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
4753263 usd
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
52563544 usd
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-107432980 usd
CY2021 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-8527786 usd
CY2023 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1851339 usd
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1717453 usd
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
286282 usd
CY2023 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
578708751 usd
CY2022 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
374447403 usd
CY2021 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
662604311 usd
CY2023 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
273733424 usd
CY2022 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
278951054 usd
CY2021 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
926351937 usd
CY2023 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
565459502 usd
CY2022 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
402242952 usd
CY2021 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
637566416 usd
CY2023 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
247083117 usd
CY2022 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
314355643 usd
CY2021 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
406800208 usd
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1005799 usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
988243 usd
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
909269 usd
CY2023 cik0001794776 Increasedecrease In Receivable For Sales Of Investments
IncreasedecreaseInReceivableForSalesOfInvestments
-30917215 usd
CY2022 cik0001794776 Increasedecrease In Receivable For Sales Of Investments
IncreasedecreaseInReceivableForSalesOfInvestments
13620479 usd
CY2021 cik0001794776 Increasedecrease In Receivable For Sales Of Investments
IncreasedecreaseInReceivableForSalesOfInvestments
5631875 usd
CY2023 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
2088555 usd
CY2022 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
2770690 usd
CY2021 us-gaap Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
2224325 usd
CY2023 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
1484858 usd
CY2022 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
-46638 usd
CY2021 us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
125387 usd
CY2023 cik0001794776 Increasedecrease In Receivable For Paydowns Of Investments
IncreasedecreaseInReceivableForPaydownsOfInvestments
208390 usd
CY2022 cik0001794776 Increasedecrease In Receivable For Paydowns Of Investments
IncreasedecreaseInReceivableForPaydownsOfInvestments
-91429 usd
CY2021 cik0001794776 Increasedecrease In Receivable For Paydowns Of Investments
IncreasedecreaseInReceivableForPaydownsOfInvestments
106157 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-568233 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
402331 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
195996 usd
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2326070 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1160678 usd
CY2023 us-gaap Increase Decrease In Payable For Investment Purchased
IncreaseDecreaseInPayableForInvestmentPurchased
-28040224 usd
CY2022 us-gaap Increase Decrease In Payable For Investment Purchased
IncreaseDecreaseInPayableForInvestmentPurchased
-61528210 usd
CY2021 us-gaap Increase Decrease In Payable For Investment Purchased
IncreaseDecreaseInPayableForInvestmentPurchased
88725508 usd
CY2023 us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
379260 usd
CY2022 us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
-373103 usd
CY2021 us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
1003097 usd
CY2022 cik0001794776 Increasedecrease In Directors Fee Payable
IncreasedecreaseInDirectorsFeePayable
5000 usd
CY2023 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-67579 usd
CY2022 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-1038008 usd
CY2021 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1676221 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
19543596 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25112684 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-438011310 usd
CY2023 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
27500000 usd
CY2022 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
81250000 usd
CY2021 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
256629745 usd
CY2023 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
28500000 usd
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
92000000 usd
CY2023 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1812482 usd
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
780621 usd
CY2023 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
33919031 usd
CY2022 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
18829187 usd
CY2021 us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
6288461 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17654225 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5023801 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
188861571 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19077288 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24555386 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
438422234 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
466308 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
557298 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
410924 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1650801 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1093503 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
682579 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2117109 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1650801 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1093503 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
42157082 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
22291491 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
7313093 usd
CY2023 cik0001794776 Distributions Declared During The Period
DistributionsDeclaredDuringThePeriod
56068285 usd
CY2022 cik0001794776 Distributions Declared During The Period
DistributionsDeclaredDuringThePeriod
44055117 usd
CY2021 cik0001794776 Distributions Declared During The Period
DistributionsDeclaredDuringThePeriod
25952493 usd
CY2023 cik0001794776 Reinvestment Of Distributions During The Period
ReinvestmentOfDistributionsDuringThePeriod
29090320 usd
CY2022 cik0001794776 Reinvestment Of Distributions During The Period
ReinvestmentOfDistributionsDuringThePeriod
24159545 usd
CY2021 cik0001794776 Reinvestment Of Distributions During The Period
ReinvestmentOfDistributionsDuringThePeriod
17683821 usd
CY2022 cik0001794776 Distributions Payable
DistributionsPayable
6941066 usd
CY2021 cik0001794776 Distributions Payable
DistributionsPayable
5874681 usd
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0529 pure
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.041 pure
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements. Actual results could differ from those estimates.</span></p>
CY2023 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Indemnifications</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the normal course of business, the Company enters into contracts that contain a variety of representations which provide general indemnifications. The Company’s maximum exposure under these arrangements cannot be known; however, the Company expects any risk of loss to be remote.</span></p>
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.90 pure
CY2023 us-gaap Quarterly Financial Information Income Taxes Significant Variation Description
QuarterlyFinancialInformationIncomeTaxesSignificantVariationDescription
In order for the Company not to be subject to U.S. federal excise taxes, it must distribute annually an amount at least equal to the sum of (i) 98% of its net ordinary income (taking into account certain deferrals and elections) for the calendar year, (ii) 98.2% of its capital gains in excess of capital losses for the one year period ending October 31 in such calendar year and (iii) any net ordinary income and capital gains in excess of capital losses for preceding years that were not distributed during such years. The Company, at its discretion, may carry forward taxable income in excess of calendar year dividends and pay a 4% nondeductible U.S. federal excise tax on this income.
CY2023 cik0001794776 Renewed Period
RenewedPeriod
P2Y
CY2023 cik0001794776 Additional Renewed Period
AdditionalRenewedPeriod
P1Y
CY2023 cik0001794776 Weighted Average Number Of Shares Outstanding Percentage
WeightedAverageNumberOfSharesOutstandingPercentage
0.0175 pure
CY2023 us-gaap Management And Service Fees Rate
ManagementAndServiceFeesRate
0.02 pure
CY2023 us-gaap Property Management Fee Percent Fee
PropertyManagementFeePercentFee
0.0175 pure
CY2023Q4 cik0001794776 Hurdle Rate Percentage In Each Quarter
HurdleRatePercentageInEachQuarter
0.015 pure
CY2023Q4 cik0001794776 Hurdle Rate Percentage In Annual Term
HurdleRatePercentageInAnnualTerm
0.06 pure
CY2023Q4 cik0001794776 Percentage Of Adjusted Net Investment Income
PercentageOfAdjustedNetInvestmentIncome
1 pure
CY2023Q4 cik0001794776 Catch Up Amount Determining Percentage
CatchUpAmountDeterminingPercentage
0.016875 pure
CY2023Q4 cik0001794776 Incentive Fee Percentage
IncentiveFeePercentage
0.125 pure
CY2023Q4 cik0001794776 Incentive Fee Percentage Equals Adjusted Net Investment Income
IncentiveFeePercentageEqualsAdjustedNetInvestmentIncome
0.125 pure
CY2023Q4 cik0001794776 Due From Advisor
DueFromAdvisor
1400000 usd
CY2023 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.142 pure
CY2023 cik0001794776 Investment Company Portfolio Turnover At Fair Value
InvestmentCompanyPortfolioTurnoverAtFairValue
0.141 pure
CY2022 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.16 pure
CY2022 cik0001794776 Investment Company Portfolio Turnover At Fair Value
InvestmentCompanyPortfolioTurnoverAtFairValue
0.163 pure
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.132 pure
CY2022Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.149 pure
CY2023Q4 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Percentage
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPercentage
1 pure
CY2022Q4 us-gaap Fair Value Investments Entities That Calculate Net Asset Value Per Share Redemption Restriction Percentage
FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareRedemptionRestrictionPercentage
1 pure
CY2023Q4 us-gaap Investments
Investments
1108810753 usd
CY2022Q4 us-gaap Investments
Investments
1017211732 usd
CY2023 us-gaap Subordinated Borrowing Interest Rate
SubordinatedBorrowingInterestRate
1.50 pure
CY2023 cik0001794776 Asset Coverage Per Unit
AssetCoveragePerUnit
1000
CY2023 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
2816166 shares
CY2023Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
46700000
CY2022 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1716297 shares
CY2022Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
29200000
CY2021 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
10007526 shares
CY2021Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
206600000
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
20000000 usd
CY2023 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
15000000 usd
CY2023 cik0001794776 Aggregate Purchase Prices
AggregatePurchasePrices
5000000 usd
CY2023 cik0001794776 Aggregate Unfunded Commitments
AggregateUnfundedCommitments
20100000 usd
CY2022 cik0001794776 Aggregate Unfunded Commitments
AggregateUnfundedCommitments
2600000 usd
CY2023 cik0001794776 Unfunded Commitments
UnfundedCommitments
20107358 usd
CY2022 cik0001794776 Unfunded Commitments
UnfundedCommitments
2636943 usd
CY2023 cik0001794776 Excise Tax Rate
ExciseTaxRate
0.04 pure
CY2023 cik0001794776 Investment Company Net Asset From Operations Increase Decrease
InvestmentCompanyNetAssetFromOperationsIncreaseDecrease
107835651 usd
CY2022 cik0001794776 Investment Company Net Asset From Operations Increase Decrease
InvestmentCompanyNetAssetFromOperationsIncreaseDecrease
-74482335 usd
CY2021 cik0001794776 Investment Company Net Asset From Operations Increase Decrease
InvestmentCompanyNetAssetFromOperationsIncreaseDecrease
19059718 usd
CY2023Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation
InvestmentOwnedUnrecognizedUnrealizedAppreciation
-52563544 usd
CY2022Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation
InvestmentOwnedUnrecognizedUnrealizedAppreciation
107432980 usd
CY2021Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation
InvestmentOwnedUnrecognizedUnrealizedAppreciation
8527786 usd
CY2023 cik0001794776 Investment Company Other Book Tax Differences
InvestmentCompanyOtherBookTaxDifferences
1677010 usd
CY2022 cik0001794776 Investment Company Other Book Tax Differences
InvestmentCompanyOtherBookTaxDifferences
8109784 usd
CY2021 cik0001794776 Investment Company Other Book Tax Differences
InvestmentCompanyOtherBookTaxDifferences
-897245 usd
CY2023Q4 us-gaap Investment Owned Unrecognized Unrealized Depreciation
InvestmentOwnedUnrecognizedUnrealizedDepreciation
56949117 usd
CY2022Q4 us-gaap Investment Owned Unrecognized Unrealized Depreciation
InvestmentOwnedUnrecognizedUnrealizedDepreciation
41060429 usd
CY2021Q4 us-gaap Investment Owned Unrecognized Unrealized Depreciation
InvestmentOwnedUnrecognizedUnrealizedDepreciation
26690259 usd
CY2023 us-gaap Investment Company Distribution Ordinary Income
InvestmentCompanyDistributionOrdinaryIncome
56068285 usd
CY2022 us-gaap Investment Company Distribution Ordinary Income
InvestmentCompanyDistributionOrdinaryIncome
43482016 usd
CY2021 us-gaap Investment Company Distribution Ordinary Income
InvestmentCompanyDistributionOrdinaryIncome
22163852 usd
CY2022 us-gaap Investment Company Distribution Long Term Capital Gain
InvestmentCompanyDistributionLongTermCapitalGain
573101 usd
CY2021 us-gaap Investment Company Distribution Long Term Capital Gain
InvestmentCompanyDistributionLongTermCapitalGain
3788641 usd
CY2023 us-gaap Partners Capital Other
PartnersCapitalOther
56068285 usd
CY2022 us-gaap Partners Capital Other
PartnersCapitalOther
44055117 usd
CY2021 us-gaap Partners Capital Other
PartnersCapitalOther
25952493 usd
CY2023 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
148613 usd
CY2021 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
1834053 usd
CY2021Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward
InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward
513796 usd
CY2023Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
9042947 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
-85947 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
-7575518 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
-101573 usd
CY2023Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation
InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation
-49754535 usd
CY2022Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation
InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation
-102926664 usd
CY2021Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation
InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation
5788994 usd
CY2023Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss
InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss
-58734816 usd
CY2022Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss
InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss
-110502182 usd
CY2021Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Ordinary Income Loss
InvestmentCompanyDistributableEarningsLossAccumulatedOrdinaryIncomeLoss
8035270 usd
CY2023Q4 us-gaap Deferred Tax Assets Other Loss Carryforwards
DeferredTaxAssetsOtherLossCarryforwards
9042947 usd
CY2023Q4 cik0001794776 Investment Tax Cost
InvestmentTaxCost
1158548300 usd
CY2022Q4 cik0001794776 Investment Tax Cost
InvestmentTaxCost
1120121398 usd
CY2021Q4 cik0001794776 Investment Tax Cost
InvestmentTaxCost
1188452438 usd
CY2023Q4 us-gaap Tax Basis Of Investments Gross Unrealized Appreciation
TaxBasisOfInvestmentsGrossUnrealizedAppreciation
9383672 usd
CY2022Q4 us-gaap Tax Basis Of Investments Gross Unrealized Appreciation
TaxBasisOfInvestmentsGrossUnrealizedAppreciation
1008264 usd
CY2021Q4 us-gaap Tax Basis Of Investments Gross Unrealized Appreciation
TaxBasisOfInvestmentsGrossUnrealizedAppreciation
9331858 usd
CY2023Q4 us-gaap Tax Basis Of Investments Gross Unrealized Depreciation
TaxBasisOfInvestmentsGrossUnrealizedDepreciation
59138207 usd
CY2022Q4 us-gaap Tax Basis Of Investments Gross Unrealized Depreciation
TaxBasisOfInvestmentsGrossUnrealizedDepreciation
103934928 usd
CY2021Q4 us-gaap Tax Basis Of Investments Gross Unrealized Depreciation
TaxBasisOfInvestmentsGrossUnrealizedDepreciation
3542964 usd
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-49754535 usd
CY2022Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-102926664 usd
CY2021Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
5788994 usd
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.96
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.06
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.15
CY2020Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20
CY2023 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
2.26
CY2022 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.78
CY2021 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.47
us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
1.32
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1.98 usd
CY2022 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-5 usd
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-0.18 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-0.19 usd
CY2023 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
4.24
CY2022 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-3.22
CY2021 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
1.29
us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
1.13
CY2023 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
2.16
CY2022 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
1.85
CY2021 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
1.01
us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
0.98
CY2022 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.03
CY2021 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.37
CY2023 us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
2.16
CY2022 us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
1.88
CY2021 us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
1.38
us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
0.98
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
17.04
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.96
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.06
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
20.15
CY2023Q4 us-gaap Shares Outstanding
SharesOutstanding
27102794 shares
CY2022Q4 us-gaap Shares Outstanding
SharesOutstanding
24286628 shares
CY2021Q4 us-gaap Shares Outstanding
SharesOutstanding
22570331 shares
CY2020Q4 us-gaap Shares Outstanding
SharesOutstanding
12562805 shares
CY2023Q4 us-gaap Assets Net
AssetsNet
461955393 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
363443482 usd
CY2021Q4 us-gaap Assets Net
AssetsNet
452797588 usd
CY2020Q4 us-gaap Assets Net
AssetsNet
253144971 usd
CY2023 us-gaap Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma
WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma
25700603 shares
CY2022 us-gaap Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma
WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma
23130666 shares
CY2021 us-gaap Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma
WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma
15494614 shares
us-gaap Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma
WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma
11156932 shares
CY2023 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.2921 pure
CY2022 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.1651 pure
CY2021 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.081 pure
us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0429 pure
CY2023 cik0001794776 Portfolio Turnover
PortfolioTurnover
0.25 pure
CY2022 cik0001794776 Portfolio Turnover
PortfolioTurnover
0.27 pure
CY2021 cik0001794776 Portfolio Turnover
PortfolioTurnover
0.53 pure
cik0001794776 Portfolio Turnover
PortfolioTurnover
0.63 pure
CY2023 us-gaap Investment Company Expense Ratio Voluntary Fee Waiver
InvestmentCompanyExpenseRatioVoluntaryFeeWaiver
0.1315 pure
CY2022 us-gaap Investment Company Expense Ratio Voluntary Fee Waiver
InvestmentCompanyExpenseRatioVoluntaryFeeWaiver
0.0828 pure
CY2021 us-gaap Investment Company Expense Ratio Voluntary Fee Waiver
InvestmentCompanyExpenseRatioVoluntaryFeeWaiver
0.0554 pure
us-gaap Investment Company Expense Ratio Voluntary Fee Waiver
InvestmentCompanyExpenseRatioVoluntaryFeeWaiver
0.0569 pure
CY2023 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.129 pure
CY2022 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0803 pure
CY2021 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0529 pure
us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0544 pure
CY2023 us-gaap Investment Company Investment Income Loss Ratio Before Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation
0.1354 pure
CY2022 us-gaap Investment Company Investment Income Loss Ratio Before Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation
0.0961 pure
CY2021 us-gaap Investment Company Investment Income Loss Ratio Before Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation
0.0692 pure
us-gaap Investment Company Investment Income Loss Ratio Before Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioBeforeIncentiveAllocation
0.0718 pure
CY2023 us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
0.1379 pure
CY2022 us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
0.0986 pure
CY2021 us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
0.0717 pure
us-gaap Investment Company Investment Income Loss Ratio After Incentive Allocation
InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation
0.0743 pure
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
26185502 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
27441864 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
28773690 usd
CY2023Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
29822551 usd
CY2023Q1 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
12592823 usd
CY2023Q2 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
13241745 usd
CY2023Q3 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
13969777 usd
CY2023Q4 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
14431742 usd
CY2023Q1 cik0001794776 Net Investments Incomeloss
NetInvestmentsIncomeloss
13592679 usd
CY2023Q2 cik0001794776 Net Investments Incomeloss
NetInvestmentsIncomeloss
14200119 usd
CY2023Q3 cik0001794776 Net Investments Incomeloss
NetInvestmentsIncomeloss
14803913 usd
CY2023Q4 cik0001794776 Net Investments Incomeloss
NetInvestmentsIncomeloss
15390809 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-317446 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2570 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2103618 usd
CY2023Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-291779 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
14813089 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
9743113 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
21152793 usd
CY2023Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
6854549 usd
CY2023Q1 us-gaap Investment Company Tax Return Of Capital Distribution
InvestmentCompanyTaxReturnOfCapitalDistribution
28088322 usd
CY2023Q2 us-gaap Investment Company Tax Return Of Capital Distribution
InvestmentCompanyTaxReturnOfCapitalDistribution
23940662 usd
CY2023Q3 us-gaap Investment Company Tax Return Of Capital Distribution
InvestmentCompanyTaxReturnOfCapitalDistribution
33853088 usd
CY2023Q4 us-gaap Investment Company Tax Return Of Capital Distribution
InvestmentCompanyTaxReturnOfCapitalDistribution
21953579 usd
CY2023Q1 us-gaap Impairment Effect On Earnings Per Share After Tax
ImpairmentEffectOnEarningsPerShareAfterTax
16.12
CY2023Q2 us-gaap Impairment Effect On Earnings Per Share After Tax
ImpairmentEffectOnEarningsPerShareAfterTax
16.55
CY2023Q3 us-gaap Impairment Effect On Earnings Per Share After Tax
ImpairmentEffectOnEarningsPerShareAfterTax
16.76
CY2023Q4 us-gaap Impairment Effect On Earnings Per Share After Tax
ImpairmentEffectOnEarningsPerShareAfterTax
17.04
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
14254960 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
16497241 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
19973554 usd
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
23774145 usd
CY2022Q1 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
5584387 usd
CY2022Q2 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
6947708 usd
CY2022Q3 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
9521115 usd
CY2022Q4 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
11365858 usd
CY2022Q1 cik0001794776 Net Investments Incomeloss
NetInvestmentsIncomeloss
8670573 usd
CY2022Q2 cik0001794776 Net Investments Incomeloss
NetInvestmentsIncomeloss
9549533 usd
CY2022Q3 cik0001794776 Net Investments Incomeloss
NetInvestmentsIncomeloss
10452439 usd
CY2022Q4 cik0001794776 Net Investments Incomeloss
NetInvestmentsIncomeloss
12408287 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-369870 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-486754 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-496697 usd
CY2022Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-6776866 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-11731503 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-74394896 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-16711415 usd
CY2022Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-4595166 usd
CY2022Q1 us-gaap Investment Company Tax Return Of Capital Distribution
InvestmentCompanyTaxReturnOfCapitalDistribution
-3430800 usd
CY2022Q2 us-gaap Investment Company Tax Return Of Capital Distribution
InvestmentCompanyTaxReturnOfCapitalDistribution
-65332117 usd
CY2022Q3 us-gaap Investment Company Tax Return Of Capital Distribution
InvestmentCompanyTaxReturnOfCapitalDistribution
-6755673 usd
CY2022Q4 us-gaap Investment Company Tax Return Of Capital Distribution
InvestmentCompanyTaxReturnOfCapitalDistribution
1036255 usd
CY2022Q1 us-gaap Impairment Effect On Earnings Per Share After Tax
ImpairmentEffectOnEarningsPerShareAfterTax
19.91
CY2022Q2 us-gaap Impairment Effect On Earnings Per Share After Tax
ImpairmentEffectOnEarningsPerShareAfterTax
16.71
CY2022Q3 us-gaap Impairment Effect On Earnings Per Share After Tax
ImpairmentEffectOnEarningsPerShareAfterTax
16
CY2022Q4 us-gaap Impairment Effect On Earnings Per Share After Tax
ImpairmentEffectOnEarningsPerShareAfterTax
14.96
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
9674876 usd
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
7869228 usd
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
8875949 usd
CY2021Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
13265600 usd
CY2021Q1 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
3637128 usd
CY2021Q2 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
3673024 usd
CY2021Q3 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
3966032 usd
CY2021Q4 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
5575228 usd
CY2021Q1 cik0001794776 Net Investments Incomeloss
NetInvestmentsIncomeloss
6037748 usd
CY2021Q2 cik0001794776 Net Investments Incomeloss
NetInvestmentsIncomeloss
4196204 usd
CY2021Q3 cik0001794776 Net Investments Incomeloss
NetInvestmentsIncomeloss
4909917 usd
CY2021Q4 cik0001794776 Net Investments Incomeloss
NetInvestmentsIncomeloss
7690372 usd
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1132657 usd
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2712837 usd
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
489555 usd
CY2021Q4 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
418214 usd
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-1826413 usd
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-1871880 usd
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-673345 usd
CY2021Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-4156148 usd
CY2021Q1 us-gaap Investment Company Tax Return Of Capital Distribution
InvestmentCompanyTaxReturnOfCapitalDistribution
5343992 usd
CY2021Q2 us-gaap Investment Company Tax Return Of Capital Distribution
InvestmentCompanyTaxReturnOfCapitalDistribution
5037161 usd
CY2021Q3 us-gaap Investment Company Tax Return Of Capital Distribution
InvestmentCompanyTaxReturnOfCapitalDistribution
4726127 usd
CY2021Q4 us-gaap Investment Company Tax Return Of Capital Distribution
InvestmentCompanyTaxReturnOfCapitalDistribution
3952438 usd
CY2021Q1 us-gaap Impairment Effect On Earnings Per Share After Tax
ImpairmentEffectOnEarningsPerShareAfterTax
20.57
CY2021Q2 us-gaap Impairment Effect On Earnings Per Share After Tax
ImpairmentEffectOnEarningsPerShareAfterTax
20.65
CY2021Q3 us-gaap Impairment Effect On Earnings Per Share After Tax
ImpairmentEffectOnEarningsPerShareAfterTax
20.7
CY2021Q4 us-gaap Impairment Effect On Earnings Per Share After Tax
ImpairmentEffectOnEarningsPerShareAfterTax
20.06
CY2023 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.26
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23130666 shares
CY2023 cik0001794776 Distributions Declared From Realized Gains
DistributionsDeclaredFromRealizedGains
usd
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
usd
CY2023 cik0001794776 Increasedecrease In Directors Fee Payable
IncreasedecreaseInDirectorsFeePayable
usd
CY2021 cik0001794776 Increasedecrease In Directors Fee Payable
IncreasedecreaseInDirectorsFeePayable
usd
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
usd
CY2021 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
usd
CY2023 us-gaap Investment Company Distribution Long Term Capital Gain
InvestmentCompanyDistributionLongTermCapitalGain
usd
CY2021Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
usd
CY2023 us-gaap Partners Capital Account Return Of Capital
PartnersCapitalAccountReturnOfCapital
usd
CY2022 us-gaap Partners Capital Account Return Of Capital
PartnersCapitalAccountReturnOfCapital
usd
CY2021 us-gaap Partners Capital Account Return Of Capital
PartnersCapitalAccountReturnOfCapital
usd
CY2022 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
usd
CY2023Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward
InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward
usd
CY2022Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Capital Loss Carryforward
InvestmentCompanyDistributableEarningsLossAccumulatedCapitalLossCarryforward
usd
CY2022Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
usd
CY2023 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001794776
CY2023Q2 dei Entity Public Float
EntityPublicFloat
0 usd

Files In Submission

Name View Source Status
0001213900-24-017740-index-headers.html Edgar Link pending
0001213900-24-017740-index.html Edgar Link pending
0001213900-24-017740.txt Edgar Link pending
0001213900-24-017740-xbrl.zip Edgar Link pending
cik0001794776-20231231.xsd Edgar Link pending
f10k2023ex21-1_palmersquare.htm Edgar Link pending
f10k2023ex31-1_palmersquare.htm Edgar Link pending
f10k2023ex31-2_palmersquare.htm Edgar Link pending
f10k2023ex32-1_palmersquare.htm Edgar Link pending
f10k2023ex32-2_palmersquare.htm Edgar Link pending
f10k2023ex97_palmersquare.htm Edgar Link pending
f10k2023_palmersquare.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
f10k2023_palmersquare_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cik0001794776-20231231_cal.xml Edgar Link unprocessable
cik0001794776-20231231_def.xml Edgar Link unprocessable
cik0001794776-20231231_lab.xml Edgar Link unprocessable
cik0001794776-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable